STATHERZ Trademark

Trademark Overview

On Tuesday, February 7, 2012, a trademark application was filed for STATHERZ with the United States Patent and Trademark Office. The USPTO has given the STATHERZ trademark a serial number of 85535917. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 21, 2015. This trademark is owned by Pfizer Inc.. The STATHERZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
statherz

General Information

Serial Number85535917
Word MarkSTATHERZ
Filing DateTuesday, February 7, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 21, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 26, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, February 11, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, September 21, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 21, 2015ABANDONMENT - NO USE STATEMENT FILED
Saturday, February 21, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, February 10, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 6, 2015EXTENSION 5 GRANTED
Friday, February 6, 2015EXTENSION 5 FILED
Friday, February 6, 2015TEAS EXTENSION RECEIVED
Wednesday, August 13, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 11, 2014EXTENSION 4 GRANTED
Monday, August 11, 2014EXTENSION 4 FILED
Monday, August 11, 2014TEAS EXTENSION RECEIVED
Friday, January 31, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, January 30, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 28, 2014EXTENSION 3 GRANTED
Tuesday, January 28, 2014EXTENSION 3 FILED
Tuesday, January 28, 2014TEAS EXTENSION RECEIVED
Saturday, August 3, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Friday, August 2, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 31, 2013EXTENSION 2 GRANTED
Wednesday, July 31, 2013EXTENSION 2 FILED
Wednesday, July 31, 2013TEAS EXTENSION RECEIVED
Wednesday, February 20, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, February 19, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 15, 2013EXTENSION 1 GRANTED
Friday, February 15, 2013EXTENSION 1 FILED
Friday, February 15, 2013TEAS EXTENSION RECEIVED
Wednesday, August 22, 2012NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 21, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 27, 2012NOTICE OF PUBLICATION
Tuesday, June 26, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 26, 2012PUBLISHED FOR OPPOSITION
Wednesday, June 6, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 17, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 16, 2012ASSIGNED TO EXAMINER
Saturday, February 11, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 10, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

statherz preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases